Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» fasinumab
fasinumab
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
Biopharma Dive
Mon, 04/22/19 - 03:37 pm
Pfizer
Eli Lilly
painkillers
tanezumab
Regeneron
Teva Pharmaceutical
fasinumab
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
CP Wire
Thu, 08/16/18 - 01:53 pm
Teva Pharmaceutical
Regeneron
fasinumab
osteoarthritis
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Thu, 08/16/18 - 09:58 am
Teva Pharmaceutical
Regeneron
fasinumab
osteoarthritis
Regeneron halts high doses of phase 3 osteoarthritis drug fasinumab amid risk-benefit concerns
Fierce Biotech
Fri, 05/4/18 - 10:05 am
Regeneron
fasinumab
clinical trials
osteoarthritis
FDA places Regeneron and Teva's pain-drug study on hold
Yahoo/Reuters
Mon, 10/17/16 - 11:56 am
FDA
Regeneron
Teva Pharmaceutical
lower back pain
fasinumab
clinical trials
Teva, Regeneron enter deal potentially worth up to $2.6 billion to develop pain therapy fasinumab
First Word Pharma
Tue, 09/20/16 - 11:11 am
Teva Pharmaceutical
Regeneron
fasinumab
painkillers
Regeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race
Seeking Alpha
Tue, 05/3/16 - 09:46 pm
Regeneron
Amgen
Pfizer
painkillers
fasinumab
clinical trials
Regeneron pain drug clears late-stage trial
Yahoo/Reuters
Mon, 05/2/16 - 10:05 am
Regeneron
clinical trials
fasinumab
osteoarthritis pain
Regeneron inks a $325M deal, selling Asian rights to a pain treatment
Fierce Biotech
Fri, 10/2/15 - 04:56 pm
Regeneron
Mitsubishi Tanabe Pharma
musculoskeletal pain
fasinumab